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Abstract
The Herpes Simplex Virus 1 (HSV-1) glycoprotein gE-gI is a transmembrane Fc receptor found on the surface of infected cells
and virions that binds human immunoglobulin G (hIgG). gE-gI can also participate in antibody bipolar bridging (ABB), a
process by which the antigen-binding fragments (Fabs) of the IgG bind a viral antigen while the Fc binds to gE-gI. IgG Fc
binds gE-gI at basic, but not acidic, pH, suggesting that IgG bound at extracellular pH by cell surface gE-gI would dissociate
and be degraded in acidic endosomes/lysosomes if endocytosed. The fate of viral antigens associated with gE-gI–bound IgG
had been unknown: they could remain at the cell surface or be endocytosed with IgG. Here, we developed an in vitro model
system for ABB and investigated the trafficking of ABB complexes using 4-D confocal fluorescence imaging of ABB
complexes with transferrin or epidermal growth factor, well-characterized intracellular trafficking markers. Our data showed
that cells expressing gE-gI and the viral antigen HSV-1 gD endocytosed anti-gD IgG and gD in a gE-gI–dependent process,
resulting in lysosomal localization. These results suggest that gE-gI can mediate clearance of infected cell surfaces of anti-
viral host IgG and viral antigens to evade IgG-mediated responses, representing a general mechanism for viral Fc receptors
in immune evasion and viral pathogenesis.
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Introduction
Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV),
and Pseudorabies Virus (PrV) are members of the alpha herpes
virus family, which are characterized by a relatively short
replicative cycle in epithelial tissues and egression to and latent
infection of the sensory neurons [1–5]. Alpha herpes viruses have
evolved many strategies to evade the host immune system. For
example, antibodies do not appear to function effectively in
clearance of HSV-1. It has been shown that the severity and
persistence of HSV-1 lesions do not correlate with serum levels of
neutralizing antibodies in infected individuals [6,7]. HSV-1
encodes type 1 transmembrane glycoproteins, glycoprotein E
(gE) and glycoprotein I (gI), that are displayed on the surface of
infected cells and virions. Together they function as a receptor for
the Fc region of human immunoglobulin G (IgG) [8,9] and have
also been implicated in cell-to-cell spread of virus [10,11]. In
addition, gE is required for HSV-1 movement inside both
neuronal and epithelial cells [12–15]. The Fc receptor function
of gE-gI, which hinders access to the IgG Fc region and thus
allows HSV-infected cells to escape recognition by Fc-dependent
effector cells, may serve as a mechanism to block antibody-related
host defenses [16].
The gE-gI heterodimer is found on the surface of both virions
and infected cells [8,17]. It has been proposed that endocytosis
signals in the cytoplasmic tails of HSV and/or VZV gE and gI
[18–20] result in uptake of gE-gI into intracellular compartments
of infected cells via clathrin-mediated endocytosis [21–23]. At
neutral pH and the slightly basic pH of the cell surface, the gE-gI
heterodimer displays a strong binding affinity (KD,340 nM) for
the Fc regions of human IgG1, 2, and 4 [8,24]. gE alone binds to
human Fc with an affinity ,100-fold weaker than the gE-gI
heterodimer (KD,30 mM) [25], whereas gI alone shows no Fc or
IgG binding activity [26]. Although endocytosis of gE-gI has been
confirmed [22,23], gE-gI-mediated uptake of IgG bound to
antigen into intracellular compartments and the fate of potentially
endocytosed IgG had not been investigated. However, the binding
affinity of gE-gI for IgG was shown to be pH dependent, with the
heterodimer displaying strong binding activity at pH 7.4 and no
binding below pH 6.0 [25]. This suggested that any IgG that was
endocytosed along with gE-gI would dissociate from gE-gI at the
acidic pH of endosomes and degradative intracellular compart-
ments, providing a potential mechanism for HSV-1 to facilitate
degradation of anti-viral IgGs.
Antibodies specific for HSV-1 antigens can be simultaneously
bound at the surface of HSV-infected cells to gE-gI via their Fc
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region and to a cell surface antigen by their antigen-binding
fragments (Fabs) (Figure 1A) [27]. This process, which is known as
antibody bipolar bridging (ABB), may be a strategy to prevent the
host from utilizing anti-HSV-1 antibodies in immune responses. It
has been shown that gE-gI can mediate ABB on the surface of
HSV-infected cells [27] and that gE-gI is required to prevent host
immune functions that require Fc binding, such as complement
activation and antibody-dependent cell-mediated cytotoxicity,
under conditions in which bipolar bridging could occur [28–30].
Although the participation of gE-gI in ABB has been
demonstrated [27], questions regarding the fate of a cell surface
ABB complex remain. Given that the cytoplasmic tails of gE and
gI include YXXQ and dileucine motifs that trigger endocytosis
[18,31,32], a bound IgG and its associated antigen might be
endocytosed together with gE-gI. In this scenario, a cell surface
viral antigen that is not normally endocytosed could be
transported to acidic compartments not in its trafficking itinerary.
The IgG/antigen complex would then presumably enter a
degradative pathway after dissociating from gE-gI at acidic pH.
Alternatively, the gE-gI/IgG/antigen complex could dissociate
prior to endocytosis, so that either the IgG/antigen complex
remained at the cell surface while gE-gI was endocytosed, or the
antigen remained at the cell surface while the gE-gI/IgG complex
was endocytosed. A final possibility is that formation of an ABB
complex would inhibit gE-gI endocytosis so that the entire
complex remained at the cell surface.
Here we describe an in vitro system using transiently-transfected
human cells to monitor the internalization and trafficking of gE-gI,
IgG, and an antigen under conditions in which ABB could or
could not occur. Under conditions that favored ABB between an
antigen and gE-gI, we found that the antigen and its bound
antibody were internalized and targeted to compartments with
lysosomal characteristics. By contrast, only background levels of
IgG and antigen were found in intracellular compartments when
the conditions did not permit IgG binding to gE-gI and/or ABB
complex formation. We also demonstrated that the internalized
surface antigen, HSV-1 gD, was localized in lysosomal compart-
ments, presumably for degradation. These results suggest that
ABB promotes the uptake of IgG and associated viral antigens,
which are directed to intracellular degradative compartments that
are not part of their normal trafficking itineraries. This provides a
mechanism for HSV-infected cells to evade IgG-mediated
immune responses by clearing host IgG and viral antigens from
the cell surface.
Results
Components of a system to investigate ABB complexes
To create a model system to study the internalization and
trafficking of ABB complexes, we co-expressed HSV-1 gE-gI and a
cell surface viral antigen, HSV-1 gD, in a human cell line (HeLa)
and then determined the effects of adding IgGs that either could or
could not form bridged complexes (Figure 1A). We chose to
investigate ABB trafficking in transfected cells rather than HSV-1–
infected cells because viral proteins other than gE, gI and gD could
introduce factors that might confound or obscure gE-gI–mediated
effects. For example, HSV-1 gM can reroute gD from the cell
surface to the trans-Golgi network [33,34].
We first established conditions under which we could express
gE-gI and characterize its interactions with different IgGs. To
avoid potential toxicity of herpes virus glycoproteins in stable cell
lines [35–37], we expressed the proteins transiently in mammalian
cells. To ensure equal levels of expression of gE and gI in the same
cell, we created a bicistronic gE-gI construct (Figure S1A) using
F2A, a picornavirus 2A-like peptide sequence [38–40]. We used 3-
D confocal immunofluorescence imaging to analyze gE and gI
expression from the bicistronic construct in fixed HeLa cells. Cells
expressing gE and gI exhibited intracellular staining for both
proteins (Figure S1B), similar to the reported localization pattern
of VZV gE [41]. Cells transfected with the gE-F2A-gI construct
showed comparable levels of both proteins, and all cells that
expressed one of the proteins also expressed the other, thus the 2A-
containing construct successfully enabled expression of both gE
and gI. Therefore staining with anti-gE could be used to verify
expression of both gE and gI in the transfected cells.
The next component of our model system involved expression
of a membrane-bound antigen. We chose HSV-1 gD, a cell
surface glycoprotein found on HSV-1 virions and infected cells
[42] for which fusion of the cytoplasmic tail to a fluorescent
protein did not affect function in viruses [43]. gD binds to host
receptors on target cells, and together with other HSV-1
glycoproteins including gB, gH and gL, it is required for HSV-1
infection in cultured cells [44]. The cytoplasmic tail of gD does not
include known endocytosis motifs [45], thus gD would be expected
to be primarily localized to the cell surface. We fused the
cytoplasmic tail of gD to a fluorescent protein (Dendra2 or
Cerulean) so that the localization of gD could be directly tracked
(gD-Dendra2) or indirectly determined using an anti-GFP
antibody (gD-Cerulean) that would not interfere with the binding
of antibodies to the gD ectodomain. We created a plasmid to
express gD alone and also a tricistronic construct to express gD
together with gE and gI by including a second picornavirus 2A-like
peptide sequence. The tricistronic construct directed expression of
gE, gI and gD (Figure S1A–C), which could also be achieved by
co-transfection of the gE-gI bicistronic construct together with the
gD expression vector. Confocal immunofluorescence imaging of
cells transfected with the gD expression plasmid alone, the gE-gI
bicistronic and gD plasmids, or the tricistronic plasmid showed gD
primarily at the cell surface, where it colocalized with a plasma
membrane marker (CellMask), and only background staining in
the cytosol and intracellular organelles (Figure 1B,C; Figure S1D).
Author Summary
Herpes Simplex Virus 1 (HSV-1) infects 40–80% of adults
worldwide. HSV-1 initiates infection at mucosal surfaces
and spreads along sensory neurons to establish a life-long
latent infection that can lead to neurological diseases.
Humans usually develop IgG antibodies that specifically
recognize pathogens via fragment antigen binding (Fab)
variable regions. HSV-1 can avoid the protective effects of
antibodies by producing gE-gI, a receptor that binds to the
constant portion of IgGs (Fc), thereby tethering the
antibody in a position where it cannot trigger downstream
immune functions. A gE-gI–bound IgG can participate in
antibody bipolar bridging (ABB) such that the Fabs bind a
viral antigen and the Fc binds gE-gI. The fate of ABB
complexes had been unknown. We used live cell fluores-
cent imaging to follow ABB complexes during their
formation and transport within a cell. We demonstrated
that ABB assemblies were internalized into acidic intracel-
lular compartments, where gE-gI dissociated from IgG–
viral antigen complexes and the IgG and antigen were
targeted for degradation within lysosomes. These results
suggest that gE-gI mediates clearance of infected cell
surfaces of both anti-viral IgGs and viral antigens, a general
mechanism to facilitate latent infection by evading IgG-
mediated responses.
HSV Antigen Clearance by Antibody Bipolar Bridging
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The final component of our model system was a set of
antibodies that could bind to both gE-gI and gD, only to gD, or
only to gE-gI. HSV-1 gE-gI exhibits a species preference for IgGs
by binding human IgG (hIgG), but not mouse IgG (mIgG) [30,46].
Thus for the anti-gD antibodies, we constructed two forms of the
monoclonal anti-gD antibody HSV8 [47,48]: one in which the
Figure 1. Cell surface complexes and analysis of HSV-1 gD localization. (A) Schematic diagrams of ABB and non-ABB complexes. Left: ABB
complex containing HSV-1 gE-gI, anti-gDhFc, and gD (gE-Fc interaction as suggested by the crystal structure of a HSV-1 gE-gI/Fc complex [77]);
middle: IgGhFc bound to gE-gI, but not gD; right: anti-gDmFc bound to gD but not gE-gI. (B,C) Representative confocal slices (from three independent
experiments in which$30 cells were analyzed) showing localization of gD-Dendra2 expressed in HeLa cells with Lysotracker (red) and CellMask (blue)
(panel B) or Lysotracker (red) and a labeled IgG (blue) (panel C). Regions of green-blue co-localization appear cyan. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1003961.g001
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Fabs were fused to a hIgG1 Fc (anti-gDhFc), which could bind to
gE-gI via its Fc and to gD via its Fabs, and one in which the Fabs
were fused to a mIgG2a Fc (anti-gDmFc), which could bind to gD
but not to gE-gI (Figure 1A). For the antibody that could bind to
gE-gI but not gD (IgGhFc), we used a hIgG against an irrelevant
antigen (HIV-1 gp120). To verify that the antibodies exhibited the
expected binding properties, we used confocal fluorescence
microscopy to demonstrate that anti-gDhFc bound to transfected
cells expressing only gD or only gE-gI, that IgGhFc bound to cells
expressing gE-gI, but not to cells expressing only gD, and that anti-
gDmFc bound to cells expressing gD but not to cells expressing only
gE-gI (Figure 1C; Figure S2). None of the antibodies bound to cells
expressing only Dendra2 or to non-transfected cells in the same
field of view (Figures S1E, 2).
Characterization of gE-gI- and gD-expressing cells
Cells expressing the gE-gI heterodimer specifically internalized
hIgG but not mIgG (Figure S2), correlating with the binding
properties of gE-gI [24]. In contrast, gE-gI–negative cells in the
same field, cells transfected with gI alone, and untransfected cells
did not internalize detectable amounts of IgG under identical
assay and imaging conditions (data not shown). Internalization of
hIgG in gE-gI–expressing cells was observed when hIgG was
incubated at pH 7.4 but not at pH 6.0 (Figure S2), correlating
with the pH-dependent binding interaction between gE-gI and
IgG [25]. Staining for gE and internalized hIgG showed some
colocalization, although many intracellular compartments were
positive for either gE alone or hIgG alone, consistent with
dissociation of hIgG from gE-gI after internalization (Figure S2,3).
In order to determine if antibody binding to gD could trigger IgG
and/or gD internalization via a gE-gI–independent mechanism,
we repeated the internalization experiments using cells expressing
only gD that had been incubated with anti-gDhFc, anti-gDmFc or
IgGhFc. Bound anti-gD antibodies remained on the cell surface
with little or no internalization and the distribution of gD-Dendra2
was not significantly changed by incubation with anti-gDhFc, anti-
gDmFc or IgGhFc (Figure 1C). These results verified that gD
localization was unaffected by incubation with antibodies in the
absence of gE-gI.
Internalization of ABB complexes
We next conducted internalization experiments on cells
expressing gE-gI and gD under conditions in which ABB
complexes either could or could not form. HeLa cells were
transiently transfected with the gE-F2A-gI and gD-Cerulean
vectors and then incubated with fluorescent-labeled anti-gDhFc,
anti-gDmFc, or IgGhFc. Cells were fixed and stained with antibodies
against gE and GFP (to localize gD-Cerulean). In samples treated
with anti-gDhFc, gD was no longer found at the plasma membrane,
but in intracellular compartments, whereas in samples treated with
either IgGhFc or anti-gDmFc, gD was localized to the cell surface,
with little or no staining in intracellular compartments (Figure 2A).
Similar results were found when cells were treated with unlabeled
versions of the three antibodies (Figure S3A). These results
suggested that under conditions in which an antibody (anti-gDhFc)
can bind to both gD and gE-gI, gD was internalized by gE as a
complex with the antibody, whereas when the antibody could bind
only to gD (anti-gDmFc) or only to gE-gI (IgGhFc), gD remained at
the cell surface. As expected, anti-gDhFc and IgGhFc were
internalized, whereas anti-gDmFc remained at the cell surface
where it colocalized with gD (Figure 2A). When gD was
internalized by addition of the anti-gDhFc antibody, gD and
anti-gDhFc localized to the same compartments, suggesting they
remained as a complex, whereas gE did not colocalize with either
anti-gDhFc or with gD in intracellular compartments, consistent
with dissociation of the antibody-gD complex from gE-gI in acidic
compartments. These observations were confirmed by quantitative
3-D colocalization analyses, which demonstrated significant
colocalization of anti-gDhFc with gD (resulting from colocalization
in intracellular compartments) but no colocalization above
background for gE with either IgG or with gD (Figure 2B). As
expected, we observed significant colocalization of anti-gDmFc with
gD, which we attributed to their binding interaction at the cell
surface, but no significant colocalization of IgGhFc with gD,
consistent with its inability to bind gD. The lack of colocalization
of IgGhFc with gE again suggested pH-dependent dissociation of
this gE-gI ligand after internalization into acidic intracellular
compartments.
Results in fixed cells were confirmed by live cell imaging. Cells
expressing gE-gI and gD were pulsed with labeled anti-gDhFc, anti-
gDmFc or IgGhFc, incubated in the absence of antibody, and then
stained with CellMask, a plasma membrane marker. Figure S3B
shows confocal images obtained 65 minutes after the labeled
antibodies were added. As demonstrated by colocalization with
CellMask staining at the plasma membrane, gD remained at the
cell surface when cells were incubated with anti-gDmFc or IgGhFc,
but was internalized when cells were incubated with anti-gDhFc.
Trafficking of ABB complexes to lysosomes
We next used live cell imaging to follow the intracellular
trafficking of ABB complex components and a lysosomal marker,
epidermal growth factor (EGF). EGF binds its cell surface receptor
to form a complex, which is internalized and traverses the low pH
environment of early endosomes, multi-vesicular bodies/late
endosomes, and is then degraded within lysosomes [49–52]. HeLa
cells transiently expressing gE, gI, and gD–Dendra2 were co-
incubated with fluorescent-labeled EGF and a labeled version of
either anti-gDhFc, IgGhFc or anti-gDmFc and 4-D live confocal
imaging was performed. At early time points in samples incubated
with anti-gDhFc, gD and anti-gDhFc fluorescence was localized at
the cell surface, and the small amount of gD and anti-gDhFc
fluorescence observed intracellularly was not in EGF-positive
compartments (Figure 3A; 10 min panel). At later time points,
increasing numbers of triple-positive intracellular vesicles staining
for EGF, gD and anti-gDhFc were observed (Figure 3A; 60 min
panel; Movie S1). These results are consistent with a model for
ABB in which anti-gDhFc–gD complexes internalized by gE-gI into
endosomal vesicles dissociated from gE-gI at low pH and then
trafficked into EGF-positive lysosomes. By contrast to gD
trafficking under ABB conditions, gD fluorescence remained
predominantly at the cell surface at all time points in cells treated
with either IgGhFc or anti-gDmFc (Figure 3B,C; Movies S2,3).
IgGhFc fluorescence was largely intracellular in EGF-negative
compartments at early time points (10 min) and in EGF-positive
compartments at later time points (60 min) (Figure 3B; Movie S2),
consistent with internalization of IgGhFc bound to gE-gI and
subsequent dissociation and targeting to EGF-positive lysosomal
compartments. Anti-gDmFc fluorescence remained mainly at the
cell surface throughout the experiment (Figure 3C; Movie S3),
consistent with binding to cell surface gD without internalization.
Statistical analyses of pairwise 3-D colocalization as a function
of time showed significant colocalization of gD with the two anti-
gD antibodies, but not with IgGhFc, at time points after 10 min of
incubation, as expected since only the anti-gD antibodies should
be bound to gD throughout the experiment (Figure 4A). When
incubated with anti-gDhFc, gD became steadily more colocalized
with EGF and anti-gDhFc after 10 min, whereas EGF was
colocalized with IgGhFc, but not gD, at later time points when
HSV Antigen Clearance by Antibody Bipolar Bridging
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incubated with IgGhFc. When incubated with anti-gDmFc, gD did
not colocalize with EGF. Addition of the microtubule depolymer-
izing agent nocodazole [53] to cells incubated with anti-gDhFc
eliminated the colocalization of EGF with gD and with anti-gDhFc,
but did not disrupt binding of anti-gDhFc to gD, as demonstrated
by colocalization of gD and anti-gDhFc (Figure 4B). These results
demonstrated that cell surface gD was exclusively internalized and
targeted into EGF-positive lysosomes under ABB conditions and
that this trafficking required intact microtubules.
To confirm these results, the experiments were repeated using
live cells incubated with Lysotracker as a lysosomal marker [54].
Statistical analyses of pairwise colocalizations as a function of time
showed similar trends (Figure S4A,B): cells incubated with anti-
gDhFc showed three pairwise colocalizations (gD with anti-gDhFc,
gD with Lysotracker, and anti-gDhFc with Lysotracker), cells
incubated with IgGhFc showed one colocalization (IgGhFc with
Lysotracker), and cells incubated with anti-gDmFc showed one
colocalization (gD with anti-gDmFc).
Figure 2. Localization of gE-gI, gD and IgG under ABB-permissive and non-permissive conditions. HeLa cells transiently expressing gE-gI
and gD-Dendra2 were incubated for 60 min at 37uC and 5% CO2 with labeled IgGs (blue) and then fixed and processed for immunofluorescence
using antibodies against gE (red) and gD-Cerulean (green). (A) Representative confocal slices (from three independent experiments in which $30
cells were analyzed) from cells treated with anti-gDhFc (top panel), IgGhFc (middle panel), or anti-gDmFc (bottom panel). Regions of gE-gD
colocalization appear yellow; regions of gD-IgG colocalization appear cyan, regions of gE-IgG colocalization appear magenta, and regions of triple
colocalization appear white. Scale bar = 10 mm. (B) 3-D thresholded Pearson correlation coefficient analyses for data from $30 cells. Correlation
coefficients are presented as the mean and standard deviation from experiments repeated at least three times. Asterisks (*) indicate a significant
difference of colocalization compared to other members in the same category (p value,0.01).
doi:10.1371/journal.ppat.1003961.g002
HSV Antigen Clearance by Antibody Bipolar Bridging
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Trafficking of ABB complexes through recycling
endosomes
To further investigate intracellular trafficking of the components
of the ABB complex, we conducted live cell imaging experiments
using labeled transferrin (Tf). Iron-loaded Tf bound to transferrin
receptor (TfR) at the slightly basic pH of the cell surface enters the
cell through receptor-mediated endocytosis, where it traffics
through endosomes, including early and recycling endosomes
[55]. The low pH of acidic endosomes triggers release of iron from
Tf in a receptor-mediated process [56–58]. Iron-depleted Tf
complexed with TfR recycles back to the cell surface, where
completely iron-free Tf (apo-Tf) dissociates from TfR upon
encountering the extracellular pH [55]. Several rounds of
endocytosis may be required to fully release iron from Tf, thus
partially iron-loaded Tf inside endosomes can be recycled to the
cell surface as a complex with TfR, where it would remain
associated with TfR, allowing another round of receptor-mediated
endocytosis into acidic compartments to facilitate release of
remaining iron from Tf [59].
Figure 3. Lysosomal trafficking of HSV-1 gD and IgG under ABB-permissive and non-permissive conditions. Representative confocal
slices from early (10 min) and late (60 min) time points from live cell imaging of HeLa cells expressing gE-gI and gD-Dendra2 (green) incubated with
EGF (red) and either anti-gDhFc (A), IgGhFc (B) or anti-gDmFc (C) (blue). Regions of EGF-gD colocalization appear yellow; regions of gD-IgG
colocalization appear cyan, regions of EGF-IgG colocalization appear magenta, and regions of triple colocalization appear white. Three independent
experiments were performed, each with analysis of $5 cells. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1003961.g003
HSV Antigen Clearance by Antibody Bipolar Bridging
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As described for the experiments with EGF, HeLa cells
transiently expressing gE, gI, and gD–Dendra2 were co-incubated
with fluorescent-labeled iron-loaded Tf and a labeled version of
either anti-gDhFc, IgGhFc or anti-gDmFc, and 4-D live cell confocal
imaging was performed. At an early time point (5 min), cells
incubated with anti-gDhFc showed anti-gDhFc and gD labeling at
the cell surface and inside the cell, with many intracellular gD–
anti-gDhFc complexes found in the same compartment as Tf
(Figure 5A). At later time points, fewer Tf-positive compartments
were also positive for gD and anti-gDhFc (Figure 5A; Movie S4).
Taken together with results demonstrating trafficking of ABB
complexes to lysosomes (Figure 3,4) and what is known about the
Tf-TfR trafficking, these observations suggested that internalized
gD–anti-gDhFc complexes first accumulated in Tf-positive early
endosomal compartments, but were subsequently sorted into
lysosomes after anti-gDhFc–gD complexes dissociated from gE-gI,
while Tf recycled as a complex with its receptor back to the plasma
membrane. IgGhFc also colocalized with Tf at the 5 min time
point, but not at later time points (Figure 5B), consistent with gE-
gI–mediated internalization of IgGhFc into Tf-positive compart-
ments followed by a diverging intracellular itinerary for IgGhFc
and Tf, with IgGhFc being routed to lysosomes after dissociation
from gE-gI. After 60 min, some regions at the cell surface showed
colocalization between gD and Tf (Figure 5B; Movie S5). As gD
was shown to remain at the cell surface upon addition of IgGhFc to
gE-gI–expressing cells (Figures 2B,3B,5C), the colocalization of gD
with Tf at the cell surface at later time points likely represents
colocalization of gD with cell surface TfR complexed with Tf that
had not completely released its iron. For similar reasons, gE-gI–
expressing cells treated with anti-gDmFc also showed colocalization
of gD with Tf (and co-localization of anti-gDmFc with Tf) at the cell
surface at later time points (Figure 5C; Movie S6).
Statistical analyses of pairwise 3-D colocalizations showed significant
colocalization of gD with the two anti-gD antibodies, but not with
IgGhFc, at time points after 5 min of incubation, as expected since only
the anti-gD antibodies should be bound to gD throughout the
experiment (Figure 6). When incubated with anti-gDhFc, Tf colocalized
at an early time point (5 min) with both gD and anti-gDhFc, likely
reflecting transient passage of anti-gDhFc–gD complexes bound to gE-
gI through Tf-positive early endosomes and subsequent re-routing of
anti-gDhFc–gD complexes through downstream Tf-negative degrada-
tive compartments. In cells incubated with IgGhFc, the IgG also
colocalized at 5 min with Tf, again likely representing endocytosis of
IgGhFc into Tf-positive compartments prior to routing to degradative
compartments. Consistent with our results and the known Tf
trafficking itinerary, colocalization of gD with Tf observed after
5 min in cells incubated with IgGhFc likely reflected colocalization of
cell-surface gD with cell-surface Tf receptor-Tf complexes formed after
an initial round of Tf endocytosis. This interpretation also explained
the observed colocalization of both gD and anti-gDmFc with Tf after
Figure 4. Pairwise colocalization analysis for ABB and non-ABB complexes with EGF. 3-D thresholded Pearson correlation coefficient
analyses (presented as the mean and standard deviation) as a function of time for data from $5 live cells in three independent experiments for each
experimental condition. (A) HeLa cells expressing gE-gI and gD-Dendra2 were incubated with labeled EGF and either anti-gDhFc (left), IgGhFc (middle)
or anti-gDmFc (right). Correlation coefficients are shown for gD versus IgG (red curve, open squares), gD versus EGF (green curve, open circles) and
EGF versus IgG (blue curve, open triangles). B) Histograms comparing correlations at 10 min (left) and 60 min (middle) time points. Right panel shows
correlations for gD versus IgG, gD versus EGF, and EGF versus IgG in anti-gDhFc samples treated with nocodazole. Asterisks (*) indicate a significant
difference of colocalization compared to other members in the same category (p-value,0.05).
doi:10.1371/journal.ppat.1003961.g004
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the 5 min time point. Tf colocalization with either gD or anti-gDmFc
did not significantly change after 5 min (Figure 6). These results
supported our hypothesis that in an ABB condition, gD and anti-gDhFc
intracellular trafficking followed a lysosomal targeting, but not a rapid
endosomal recycling, pathway.
Discussion
Antibody bipolar bridging (ABB), in which an anti-viral IgG
bound to a cell surface antigen also binds to an Fc receptor, has
the potential to protect virions and infected cells from IgG-
mediated immune responses. gE-gI is an HSV-1 heterodimeric
complex that can function as a receptor for human IgGs by
binding to their Fc regions [9], thus it can mediate ABB in HSV-
1–infected cells. Experiments performed in HSV-1-infected cells to
compare the efficacy of IgGs that can or cannot form ABB
complexes suggested that bipolar bridging protects HSV-1 and
HSV-1–infected cells from antibody- and complement-dependent
neutralization [27], antibody-dependent cell-mediated cytotoxicity
[30], and granulocyte attachment [29]. Since gE-gI is endocytosed
Figure 5. Endosomal trafficking of HSV-1 gD and IgG under ABB-permissive and non-permissive conditions. Representative confocal
slices (from three independent experiments, each involving $5 cells) from early (5 min) and late (60 min) time points from live cell imaging of HeLa
cells expressing gE-gI and gD-Dendra2 (green) incubated with Tf (red) and anti-gDhFc (A), IgGhFc (B) or anti-gDmFc (C) (blue). Regions of Tf-gD
colocalization appear yellow, regions of gD-IgG colocalization appear cyan, regions of Tf-IgG colocalization appear magenta, and regions of triple
colocalization appear white. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1003961.g005
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[18], associated IgGs are predicted to be taken into intracellular
compartments along with the viral receptor, as we have now
demonstrated (Figure S2). The fate of a cell surface ABB complex
remained unknown. Given that most antibodies bind protein
antigens with high affinities roughly comparable to the nM affinity
of gE-gI for IgG [25], it was possible that antigen-antibody
complexes would remain associated during gE-gI-mediated
endocytosis such that internalization of gE-gI could indirectly
cause uptake of cell surface viral antigens, redirecting them and
any associated IgGs to acidic intracellular compartments. This
would allow the virus to clear the cell surface of viral antigens and
anti-HSV-1 IgGs. Here we constructed an in vitro system to
monitor the trafficking of bipolar bridged complexes involving the
HSV-1 Fc receptor gE-gI, the HSV-1 antigen gD, and IgGs.
Cells expressing gE-gI and gD were incubated without IgG or
with one of three forms of IgG: anti-gDhFc (binds gD and gE-gI),
anti-gDmFc (binds gD only), and IgGhFc (binds gE-gI only)
(Figure 1A). We then used confocal fluorescence microscopy to
localize the HSV-1 proteins, the IgGs, and intracellular markers.
In the absence of IgG, gE-gI was mainly intracellular, whereas gD
was primarily at the cell surface (Figure S1C). This distribution did
not change appreciably when cells were incubated with IgGs that
could not form ABB complexes (anti-gDmFc or IgGhFc), but we
observed an increase of gD inside intracellular compartments
upon addition of anti-gDhFc, an IgG that could participate in ABB
(Figure 2). In order to objectively evaluate the images, we
performed quantitative colocalization studies of ABB components
and intracellular markers (Tf for early and sorting endosomes; EGF
and Lysotracker for lysosomes) in at least 30 fixed cells and five live cells
for each experimental condition. In cells treated with anti-gDhFc, these
studies showed a significant increase of gD in early endosomes and
sorting endosomes at early time points followed by transport of gD into
lysosomes, by contrast to the primarily cell surface localization of gD in
cells treated with IgGhFc or anti-gDmFc (Figure 3–6). Given that
addition of anti-gDhFc or anti-gDmFc or IgGhFc did not cause
redistribution of gD to intracellular compartments in cells that did
not express gE-gI (Figure 1C), these results demonstrated that ABB
complexes were endocytosed along with gE-gI. Although these
experiments were done in transfected cells, extrapolating these results
to virally-infected cells would provide a mechanism by which HSV-
infected cells can sequester both anti-HSV-1 antibodies and viral
antigens from the host immune system (Figure 7).
Other studies have demonstrated that ABB resulting from
addition of polyclonal anti-HSV-1 antibodies induced patching,
capping and extrusion of alpha-herpes viral glycoproteins in some
cell lines, another means of removing viral antigens from the
surfaces of infected cells [60,61]. Large cross-linked complexes of
gE-gI–IgG–antigen could form upon binding of polyclonal
antisera containing anti-gE or anti-gI antibodies. The decision to
extrude or endocytose an ABB complex might depend on whether
the complex exceeds the ,200 nm size threshold for clathrin-
mediated endocytosis [32].
Figure 6. Pairwise colocalization analysis for ABB and non-ABB complexes with Tf. 3-D thresholded Pearson correlation coefficient
analyses (presented as the mean and standard deviation) as a function of time for data from $5 cells in three independent experiments for each
experimental condition. (A) HeLa cells expressing gE-gI and gD-Dendra2 were incubated with Tf and either anti-gDhFc (left), IgGhFc (middle) or anti-
gDmFc (right). Correlation coefficients are shown for gD versus IgG (red curve, open squares), gD versus Tf (green curve, open circles) and Tf versus IgG
(blue curve, open triangles). (B) Histograms comparing correlations (presented as the mean and standard deviation) at 5 min (left), 15 min (middle)
and 60 min (right). Asterisks (*) indicate a significant difference of colocalization compared to other members in the same category (p value,0.05).
doi:10.1371/journal.ppat.1003961.g006
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The sharply pH-dependent binding affinity of the gE-gI–IgG
interaction (binding at pH 7.4 but not pH 6.0) [25] suggested that IgGs
bound to gE-gI at the slightly basic pHof the cell surfacewould dissociate
upon encountering the acidic pH of endosomes. Since antibody-antigen
interactions are normally stable over the same pH range, an antigen-IgG
complex would likely remain associated after the IgG dissociated from
gE-gI. This assumption is consistent with our data that showed
colocalization of gD and anti-gD throughout the course of incubation
(Figures 2–6). Additionally, we observed relatively low correlation
coefficients for gE colocalization with gDwhen cells were incubated with
anti-gDhFc, and for gE with hIgGs when cells were incubated with anti-
gDhFc or IgGhFc (Figure 2C). Separation of the intracellular trafficking
itineraries of gE-gI and IgG–antigen complexes would allow the bulk of
gE-gI molecules to be recycled back to the cell surface, likely passing
through the ER-Golgi compartments [62,63], while IgG–antigen
complexes that had dissociated from gE-gI would traffic to increasingly
acidic compartments, ultimately being targeted to lysosomes for
degradation (Figure 7). This scenario is supported by the preferential
colocalization of gD with lysosomal markers when cells were incubated
with anti-gDhFc (Figures 3A,4), and IgGs with EGF when cells were
incubated with either of anti-gDhFc or IgGhFc (Figures 3A,B,4).
Both degradative and recycling pathways could be used to
further the agenda of HSV-1 in infected cells: with each new
infective event HSV-1 only needs to evade the host humoral
immune system for a finite amount of time before nascent viral
particles are competent to spread to uninfected cells and new
hosts. Internalization of ABB complexes and consequent degra-
dation or recycling offers an elegant solution for HSV-1 to clear
membrane proteins that serve as antigenic targets and to
selectively remove anti-HSV-1 antibodies, thereby preventing
IgG-mediated immune effector functions.
Materials and Methods
DNA constructs for HSV-1 gD, gE and gI expression in
mammalian cells
Genes for HSV-1 gE, gI and gD were provided by Dr.
Homayon Ghiasi, Cedars-Sinai Medical Research Institute. Single
Figure 7. Model of ABB and non-ABB component trafficking. Cell surface ABB complexes (the Fc of anti-gDhFc bound to gE-gI and the Fabs
bound to gD) are endocytosed into early endosomes (EE) and sorting endosomes (SE). Upon acidification, the Fc region of anti-gDhFc dissociates from
gE-gI but the Fabs remain bound to gD. The IgG-gD complex then enters the lysosomal pathway (Lys) to be degraded. Intracellular trafficking of
compartments containing ABB components depends upon intact microtubules (thin straws adjacent to intracellular vesicles). Free gE-gI could be
trafficked via a retrograde pathway to the Golgi/ER network and recycling endosomes (RE) before recycling back to the cell surface. IgGhFc bound to
gE-gI traffics similarly, but does not recruit cell surface gD into ABB complexes. Anti-gDmFc remains bound to gD at the cell surface.
doi:10.1371/journal.ppat.1003961.g007
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promoter DNA constructs expressing either one or multiple HSV-
1 genes were made using the In-Fusion Enzyme kit from Clontech
Inc. (Mountain View, CA), which uses a $15 bp overlap to fuse
DNA fragments and a linearized vector. To prepare the gD
constructs, HSV-1 gD and fluorescent protein (Cerulean or
Dendra2) gene sequences were amplified by PCR and subcloned
into the pCEP4 mammalian expression vector (Life Technologies,
Carlsbad, CA) such that the fluorescent protein was fused C-
terminal to the cytoplasmic tail of gD (Figure S1A). Confocal
imaging using anti-gD antibodies for staining revealed no
systematic differences in localizations of gD compared with gD-
Cerulean or gD-Dendra2 (data not shown).
To co-express gE and gI from the same mRNA, a spacer
encoding a furin protease site (R-X-R/K/X-R) [64], a flexible
linker (S-G-S-G) and a picornavirus F2A peptide sequence [65]
were inserted between the HSV-1 gE and gI gene sequences in a
pCDNA4.0.TO vector [65–67] (Figure S1B). The flexible linker
between the N-terminal gE protein and the 2A peptide sequence
was added to improve the efficiency of the ribosomal skip
mechanism [65,68,69], and the furin cleavage site was added to
remove remnants of the linker and P2A sequences. To construct
the gE-gI bicistronic vector, the gE gene was modified by PCR to
include a 17 bp overlap and a 59 Not I site, and the gI gene was
modified to insert the furin-linker-F2A sequence at its 59 (N-
terminal) end, and a Kpn I site and a 17 bp overlap at its 39 (C-
terminal) end. Both PCR cassettes were fused onto the pCDNA4.0
vector, previously linearized with NotI and KpnI restriction
enzymes, using the In-Fusion enzyme kit (Clontech).
To co-express HSV-1 gE, gI and gD-Dendra2 from a single
mRNA, we inserted a second form of 2A sequence (a porcine
teschovirus-1-derived 2A (P2A) peptide sequence [70]) between gI
and gD-Dendra2 to create a tricistronic construct (Figure S1A).
The gE-F2A-gI encoding sequence was modified by PCR to
include a 17 bp overlap at the 59 end of the gE gene and a Kpn I
site plus the P2A peptide sequence [70] at the 39 end of the gI
gene. The HSV-1 gD-Dendra2 sequence was modified by PCR to
insert the P2A sequence at the 59 end of the gD gene and an
EcoRI site and a 17 bp overlap at the 39 end of the Dendra2 gene.
Both PCR cassettes were fused onto the pCDNA4.0 vector,
previously linearized with NotI and EcoRI, using the In-Fusion
enzyme kit.
Expression and purification of antibodies
Genes for the heavy and light chains of the anti-gD antibody
HSV8 [48] were provided by Dr. Stephen Mayfield, Scripps
Research Institute. The HSV8 light chain gene was modified by
PCR to include 59 and 39 EcoRI sites and then ligated into the
pCDNA3.1 mammalian expression vector (Life Technologies).
The portion of the HSV8 heavy chain gene encoding the Fab VH
and CH1 domains was modified by PCR to include a 59 XhoI site
and a 39 SpeI site and then subcloned into the pAc-k-Fc
baculovirus expression vector (PROGEN Biotechnik), which
includes the gene for the human IgG1 Fc (hFc). This gene was
modified by PCR to include 59 and 39 BamHI sites and then
subcloned into the pCDNA3.1 expression vector using the BamHI
site. To make an anti-gD antibody with a mouse Fc region (mFc),
PCR was used to insert a 59 BamHI site and a 39 bridging
sequence (21 nucleotides encoding the end of the HSV8 Fab
followed by 20 nucleotides encoding the IgG2a mFc). The Fc
portion of the mIgG2a gene (InvivoGen, San Diego, CA) was
modified by PCR to include the bridging sequence and a 39
BamHI site. The two products were mixed together and PCR
amplified to generate the anti-gDmFc fusion, which was then
ligated into the pCDNA3.1 mammalian expression vector (Life
Technologies).
Antibodies were expressed by co-transfection of heavy and light
chain expression vectors to produce anti-gDhFc and anti-gDmFc
(anti-gD antibodies with a human or a mouse Fc region), and
IgGhFc (2G12, a human IgG1 antibody against HIV gp120)
[71,72]. The genes were co-expressed by transient expression in
293T cells using a cationic liposome transfection procedure
(Lipofectamine 2000, Life Technologies). Six days post-transfec-
tion, IgGs were purified from the harvested media by Protein A
chromatography using Protein A agarose beads (Pierce/Thermo-
Scientific). The IgGhFc antibody was passed over a Superdex 200
16/60 or 10/30 gel filtration column (GE Healthcare) to separate
IgG dimer from IgG monomer [73]. The IgG monomer fraction
was used for experiments. All of the other IgGs migrated as typical
IgG monomers by gel filtration chromatography (data not shown).
Antibody labeling
Mouse monoclonal anti-gE was from Virusys (Sykesville, MD)
and mouse monoclonal anti-gI (2E9) was a gift from Dr. Malini
Raghavan (University of Michigan Medical School) [61]. These
antibodies and the expressed antibodies (anti-gDhFc, anti-gDmFc,
and IgGhFc) were directly conjugated to Alexa fluor (AF) dyes
(AF488-NHS, AF568-NHS, or AF647-NHS; Life Technologies,
Inc.) according to the manufacturer’s protocol. Labeled antibodies
were separated from unconjugated dye using a 10,000-kDa cutoff
dextran desalting column (Pierce/Thermo-Scientific, Rockford,
IL, USA), and the concentration and degree of labeling were
determined spectrophotometrically following protocol described
by Life Technologies, Inc.
Cell culture, transfection and preparation
HeLa cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) medium (Life Technologies) supplemented with 10%
heat inactivated fetal bovine serum (HyClone, Logan, UT) and
100 mg/mL penicillin/streptomycin mix (Sigma, St. Louis, MO),
and incubated at 37uC under a 5% CO2 atmosphere. Fully
confluent cells were detached using 0.25% (w/v) trypsin-EDTA
(Life Technologies) and passaged every 3 days.
Attempts to make stable HeLa cell lines constitutively expressing
gE, gI, or both proteins were unsuccessful, presumably due to
toxicity associated with expression of these proteins [37]. A stable
cell line expressing VZV gE under the control of an inducible
promoter was reported [19]. We therefore attempted to use a dual
induction system involving expression of gE under the control of a
tetracycline-inducible promoter [74] and expression of gI under
the control of a cumate-inducible promoter [75]. Although we
were able to create a stable HeLa cell line expressing an inducible
gE, we were unable to isolate stable cell lines that expressed gI
after induction, either in the gE-inducible cell line or in cells that
did not express gE (data not shown). We therefore switched to
transient transfections to express gE, gI and gD for short periods of
time. The gE-F2A-gI, gE-F2A-gI-P2A-gD-Dendra2 and gD-
Cerulean expression vectors were transiently transfected either
alone or in various combinations into HeLa cells using a cationic
liposome transfection procedure (Lipofectamine 2000, Life Tech-
nologies). At least 18 hours post-transfection, the cells were treated
with 75 mg/mL cycloheximide (Sigma-Aldrich, St Louis, MO) to
attenuate intracellular staining of newly synthesized proteins in the
endoplasmic reticulum or Golgi apparatus. Two hours later, the
cells were rinsed in Hank’s Balanced Salt Solution, 10 mM MES
pH 6.0, 1% ovalbumin, and 75 mg/mL cycloheximide (M1 buffer)
at 37uC for 5 min to remove trace amounts of bovine IgG in the
ultra-low IgG serum used for cell culture (the pH was lowered to
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6.0 to promote dissociation of any bovine IgG present in the serum
that might be bound to cell surface gE-gI). The cells were then
incubated at 37uC with 2 mg/mL labeled or unlabeled IgG (either
anti-gDhFc, anti-gDmFc, or IgGhFc) in a serum-free Leibovitz’s L-15
medium (Life Technologies) and 75 mg/mL cycloheximide at
37uC with 5% CO2.
Cell surface localization of HSV-1 gD
Hela cells transiently expressing only gD-Cerulean or gD-
Dendra2 were incubated with 50 nM Lysotracker (Life Technol-
ogies), a lysosomal marker conjugated to AF568 dye in L-15
medium (Life Technologies) at 37uC with 5% CO2 atmosphere.
After 30 min, unincorporated dye was removed by rinsing the
preparations three times with fresh, pre-warmed L15 medium.
Samples were then stained for 5 min under the same conditions
with a plasma membrane marker (0.5 mg/mL CellMask dye; Life
Technologies) or a mitochondrial marker (25 nMMitotracker dye;
Life Technologies), which had been labeled with AF647. To
analyze the binding specificity and impact of antibodies on the gD-
Cerulean or gD-Dendra2 distribution, cells expressing only gD
were pulsed for 60 min at 37uC and 5% CO2 with either anti-
gDmFc, anti-gDhFc, or IgGhFc conjugated with AF647 dye to a final
concentration of 2 mg/mL in L15 medium supplemented with
75 mg/mL of cycloheximide, and then with 50 nM AF568-labeled
Lysotracker dye for 5 min under the same conditions. Cells
expressing only Dendra2 were included as controls (Figure S1A).
Samples were directly imaged live or fixed and processed for
immunofluorescence.
pH-dependent uptake analyses
HeLa cells transiently expressing HSV-1 gE-gI, but not HSV-1
gD, were washed with a M1 buffer (pH 6.0) to remove any serum
bovine IgG bound to gE-gI. Cells were then incubated at pH 7.4
or pH 6.0 with AF488-labeled anti-gDhFc, anti-gDmFc or IgGhFc
(final concentration of 2 mg/mL). After 15 min, cells were rinsed
to remove unbound antibodies, and samples were returned to the
incubator to allow potential endocytosis of gE-gI–IgG complexes.
After 45 min, samples were rinsed three times in sterile 16 PBS
and then fixed in 4% paraformaldehyde for 30 min at room
temperature (RT) or over-night at 4uC. Fixed cells were processed
for immunofluorescence and stained with 5 mg/mL of primary
antibodies against HSV-1 gE and gI directly conjugated with
AF568 and AF647 dyes, respectively, and with 0.5 mg/mL of the
nucleic acid-specific dye 49,6-diamidino-2 phenylindole dihydro-
chloride (DAPI) (Life Technologies, Inc.). Samples were imaged
and recorded on an Ultra View ERS Rapid Confocal Imager
(PerkinElmer, Inc.) using a 1006 objective (aPlan-APOCHRO-
MAT 1.46 Oil DIC, Zeiss). AF488, AF546, and AF647 dyes were
excited at 488 nm, 568 nm, and 647 nm, respectively, using a
multi-line argon/krypton laser (Miles-Griot).
Characterization of HSV-1 gE-gI and gD localization
under ABB-permissive and non-permissive conditions
HeLa cells transiently expressing HSV-1 gE-gI and gD-
Dendra2 or gD-Cerulean were incubated for 60 min with
AF647-conjugated or with unlabeled anti-gDhFc, anti-gDmFc, or
IgGhFc at a final concentration of 2 mg/mL. Samples fixed in 4%
PFA were processed for immunofluorescence and stained with
AF568-labeled primary antibodies against gE. Samples incubated
with unlabeled anti-gDhFc, anti-gDmFc, or IgGhFc IgGs were
immunostained with 5 mg/mL of anti-gI antibody conjugated with
AF647. 3-D multi-channel fluorescence confocal images of both
treated and non-treated transfected cells were acquired using a
Zeiss Laser Scanning Microscope 510 (LSM510), and analyzed
with both Imaris 7.6.1 and Image/Fiji software.
Fixed cell immunofluorescence confocal microscopy
Transfected cell samples seeded on 12 mm round coverslips or
on Lab-Tek chambered coverglass bottom dishes (Thermo
Scientific/Nunc, Rochester NY) were pulsed with either labeled
or unlabeled anti-gDhFc, anti-gDmFc and IgGhFc IgGs. Samples
were then fixed in 4% PFA for at least 20 min at RT, rinsed three
times in 16 PBS, quenched in 50 mM NH4Cl/16 PBS solution
for 5 min at RT. Fixed samples were simultaneously blocked and
permeabilized in 2% (w/v) chicken serum albumin (CSA)/16
PBS/0.25% (v/v) Triton X-100 for 60 min at RT or 4uC
overnight. Incubations with directly-labeled primary antibodies
were performed in blocking solution overnight at 4uC. Cells were
washed three times in 0.25% (v/v) Triton X-100/16PBS and 16
PBS solutions before mounting on glass slides using Pro-long
GOLD anti-fade mounting media containing DAPI (Life Tech-
nologies). Samples were imaged either on the a Zeiss LSM510
Meta NLO with Coherent Chameleon fitted with a 636objective
lens (aPlan-APOCHROMAT 1.45 Oil DIC) or an Ultra View
ERS Rapid Confocal Imager (PerkinElmer, Inc.) using a 1006
objective (aPlan-APOCHROMAT 1.46 Oil DIC, Zeiss). DAPI
was excited at 350 nm/DAPI filter or at 725 nm with a two-
photon unit attached to the LSM510 microscope. 3-D confocal
stacks were sampled at 0.2–1 mm intervals. Confocal images
shown are representative slices from 3-D confocal stacks sampled
at 0.5 mm intervals unless otherwise indicated.
HSV-1 gD and IgG internalization assay
Transfected cells were pulsed for 30 min at 37uC and 5% CO2
with AF647-conjugated anti-gDmFc, anti-gDhFc, or IgGhFc (final
concentration 2 mg/mL) in L15 medium supplemented with
75 mg/mL of cycloheximide. Cultures were rinsed with pre-
warmed L15 medium to remove excess IgG. After 30 min, AF568-
conjugated CellMask (Life Technologies) was added into the
medium at a final concentration of 0.5 mg/mL. After 5 min,
samples were rinsed with fresh pre-warmed medium, and multi-
channel z-stack images were captured using a 636 objective lens
(aPlan-APOCHROMAT 1.45 Oil DIC) on a Zeiss LSM510
microscope.
4-D confocal microscopy
Transfected cells co-expressing gE-gI and gD-Dendra2 were co-
incubated with AF568-conjugated EGF or Lysotracker at a
concentration of 50 nM in 75 mg/mL cycloheximide/L15 medi-
um at 37uC and 5% CO2. After 30 min, samples in Lab-Tek
chambered cover-glass bottom dishes (Thermo Scientific/Nunc)
were rinsed to remove excess dye and fresh medium was added. 4-
D multi-channel confocal imaging was performed using a 636
objective lens (aPlan-APOCHROMAT 1.45 Oil DIC) on a
LSM510 microscope (Zeiss) at a 37uC and a 5% CO2 atmosphere
using a motorized temperature-controlled stage, an environmental
chamber, and a CO2 enrichment system. After imaging an initial
z-stack (0.5–1 mm section thickness and up to 16 mm total depth),
the ZEN 2009 software (Zeiss) was paused and AF647-conjugated
anti-gDmFc, anti-gDhFc, or IgGhFc was added to a final concen-
tration of 2 mg/mL. The software was then re-activated and multi-
channel z-stacks were captured approximately every 3 min for at
least one hour. Images were acquired and processed by an
electron-multiplying CCD (charge-coupled device) camera (Ha-
mamatsu Photonics).
Tf-based experiments were performed similarly except that
AF568-conjugated Tf was mixed with AF647-conjugated IgG
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(concentrations of 1 mg/mL and 2 mg/mL, respectively) before
being added into the culture after the 3-D image of the first time
point was captured.
Quantification, statistical analysis and image processing
Imaris 7.6.0, ImageJ, Photoshop CS and Illustrator CS (Adobe)
software were used for image processing. Both 3-D and 4-D
colocalization analyses were performed using Imaris 7.6.0 software
(Bitplane; Zurich, Switzerland), and the thresholded Pearson’s
correlation coefficient (PCC) in the colocalized volume was
determined for each sample. At least 30 transfected cells were
examined for each 3-D experiment, and $5 live cells were
analyzed for each 4-D experiment. Data were based on three or
more independent experiments and are presented as mean 6
standard deviation. For each pair-wise colocalization analysis, the
voxel intensity threshold was set using the background subtraction
function as implemented in the Imaris colocalization module [76].
The region of interest dataset was set by a channel based-mask.
Correlation values were calculated using the automatic threshold
function with a P-value = 1 and a point spread function width of
0.141 mm. Statistical analysis and graphs were done using Prism5
(GraphPad). Two-way ANOVA was performed on each set of
mean correlation values and P-values were calculated with a
Student-Newman-Keuls post-test.
Supporting Information
Figure S1 Characterization of DNA constructs. (A)
Schematics of mammalian expression vectors. CMV indicates a
cytomegalovirus promoter, gE, gI and gD are the genes for HSV-1
gE, gI and gD, each including its hydrophobic leader peptide, F2A
and P2A indicate sequences resulting in cleavage between the two
indicated gene products. (B) Representative image of HeLa cells
transiently expressing gE (red) and gI (blue) from the bicistronic
gE-gI vector, with nuclei stained in white. (C) Representative
image of a HeLa cell transiently expressing gE (red), gI (blue) and
gD-Dendra2 (green) from the tricistronic vector. (D) Representa-
tive image of a HeLa cell transiently expressing gD-Dendra2
(green), which was stained with 50 nM Lysotracker (red) and
25 nM Mitotracker (blue). (E) Representative image of a HeLa cell
transiently expressing cytoplasmic Dendra2, which does not co-
localize with Lysotracker or stain with anti-gD IgGs (results are
shown for anti-gDmFc; similar results were obtained for anti-gDhFc
and IgGhFc; data not shown). Scale bar = 10 mm.
(TIF)
Figure S2 pH-dependent binding of gE-gI to human
IgG. Cells transiently expressing gE-gI, but not gD, were pulsed
for 60 min at pH 7.4 or pH 6.0 with anti-gDhFc (A), IgGhFc (B) or
anti-gDmFc (C) (green). Fixed cells were stained with antibodies
against gE (red) and gI (blue). The experiments were repeated at
least three times with analysis of $30 cells. Scale bar = 10 mm.
(TIF)
Figure S3 Redistribution of cell surface gD under ABB
conditions. (A) HeLa cells transiently expressing gE-gI and gD-
Dendra2 were incubated with unlabeled IgGs (blue) for 60 min
and then fixed and processed for immunofluorescence using
antibodies against gE (red) and gD-Dendra2 (green). Representa-
tive confocal slices from cells treated with anti-gDhFc (top), IgGhFc
(middle), or anti-gDmFc (bottom). Regions of gE-gD colocalization
appear yellow; regions of gD-gI colocalization appear cyan,
regions of gE-gI colocalization appear magenta, and regions of
triple colocalization appear white. Scale bar = 10 mm. (B) Live
HeLa cells expressing gE-gI and gD-Dendra2 were pulsed with
labeled IgGs (blue) for 60 min and then treated with CellMask
(red), a plasma membrane marker, for 5 min. Representative
confocal slices from cells treated with anti-gDhFc (top), IgGhFc
(middle), or anti-gDmFc (bottom). Regions of gE-gD colocalization
appear yellow; regions of gD-IgG colocalization appear cyan,
regions of gE-IgG colocalization appear magenta, and regions of
triple colocalization appear white. The experiments were repeated
at least three times with analysis of $30 cells. Scale bar = 10 mm.
(TIF)
Figure S4 Intracellular trafficking and lysosomal tar-
geting of HVS-1 gD and hIgG. (A) 3-D thresholded Pearson
correlation coefficient analyses as a function of time for data from
$5 live cells in at least three independent experiments for each
experimental condition. HeLa cells expressing gE-gI and gD-
Dendra2 were incubated with Lysotracker and either anti-gDhFc
(left), IgGhFc (middle) or anti-gDmFc (right). Correlation coefficients
are shown as the mean and standard deviation for gD versus IgG
(red curve, open squares), gD versus Lysotracker (green curve,
open circles) and Lysotracker versus IgG (blue curve, open
triangles). (B) Histograms comparing correlations at 10 min (left)
and 60 min (right) time points. Asterisks (*) indicate a significant
difference of colocalization compared to other members in the
same category (p value,0.01).
(TIF)
Movie S1 4-D movie of ABB-dependent trafficking of gD
and anti-gDhFc to lysosomes (corresponds to Figure 3A).
Live cell imaging of HeLa cells expressing gE-gI and gD-Dendra2
(green) incubated with EGF (red) and anti-gDhFc (blue). Regions of
EGF-gD colocalization appear yellow; regions of gD-IgG
colocalization appear cyan, regions of EGF-IgG colocalization
appear magenta, and regions of triple colocalization appear white.
4-D multi-channel confocal imaging was performed using a 636
oil objective lens (aPlan-APOCHROMAT 1.45 Oil DIC) on a
LSM510 microscope (Zeiss) and an electron-multiplying charge-
coupled device (CCD) camera (Hamamatsu Photonics), controlled
by the ZEN 2009 software (Zeiss). Z-stacks (at 1 mm section
thickness and up to 16 mm total depth) were captured approxi-
mately every 3 min for ,90 min. The video was recorded at a
time resolution of approximately 5 seconds per frame and
presented at 10 frames per second. The equatorial planes for z-
stack sections are shown on this video.
(AVI)
Movie S2 4-D movie of trafficking of IgGhFc, but not
HSV-1 gD, to lysosomes under non-ABB conditions
(corresponds to Figure 3B). Live cell imaging of HeLa cells
expressing gE-gI and gD-Dendra2 (green) incubated with EGF
(red) and IgGhFc (blue). Regions of EGF-IgGhFc colocalization
appear magenta. 4-D multi-channel confocal imaging was
performed under conditions described for Supplementary Movie
S1.
(AVI)
Movie S3 4-D movie showing no trafficking of either gD
or anti-gDmFc to lysosomes under non-ABB conditions
(corresponds to Figure 3C). Live cell imaging of HeLa cells
expressing gE-gI and gD-Dendra2 (green) incubated with EGF
(red) and anti-gDmFc (blue). Regions of gD-anti-gDmFc colocaliza-
tion appear cyan. 4-D multi-channel confocal imaging was
performed under conditions described for Supplementary Movie
S1.
(AVI)
Movie S4 4-D movie of ABB-dependent trafficking of
HSV-1 gD and anti-gDhFc to Tf-negative intracellular
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compartments (corresponds to Figure 5A). 4-D confocal
imaging of cells expressing gE-gI and gD-Dendra2 (green) treated
with anti-gDhFc (blue) and Tf (red). Regions of Tf-gD colocaliza-
tion appear yellow; regions of gD-anti-gDhFc colocalization appear
cyan, regions of Tf-anti-gDhFc colocalization appear magenta, and
regions of triple colocalization appear white. 4-D multi-channel
confocal imaging was performed under conditions described for
Supplementary Movie S1.
(AVI)
Movie S5 4-D movie of trafficking of IgGhFc, but not
HSV-1 gD, to Tf-negative intracellular compartments
under non-ABB conditions (corresponds to Figure 5B). 4-
D confocal imaging of cells expressing gE-gI and gD-Dendra2
(green) treated with IgGhFc (blue) and Tf (red). Regions of Tf-gD
colocalization appear yellow; regions of gD-IgGhFc colocalization
appear cyan, and regions of Tf-IgGhFc colocalization appear
magenta. 4-D multi-channel confocal imaging was performed
under conditions described for Supplementary Movie S1.
(AVI)
Movie S6 4-D movie showing no trafficking of either gD
or anti-gDmFc to Tf-negative intracellular compartments
under non-ABB conditions (corresponds to Figure 5C). 4-
D confocal imaging of cells expressing gE-gI and gD-Dendra2
(green) treated with anti-gDmFc (blue) and Tf (red). Regions of Tf-
gD colocalization appear yellow; regions of gD-anti-gDmFc
colocalization appear cyan, regions of Tf-anti-gDmFc colocaliza-
tion appear magenta, and regions of triple colocalization appear
white. 4-D multi-channel confocal imaging was performed under
conditions described for Supplementary Movie S1.
(AVI)
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